RAFAEL HOLDINGS, INC. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
RAFAEL HOLDINGS, INC. (RFL) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $8.40 million for the 9-month period ending 2019-04-30, per its 10-Q filed 2019-06-05.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2019-06-05
- RAFAEL HOLDINGS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for the quarter ending 2019-04-30 was $0.00, a 100.00% decline year-over-year.
- RAFAEL HOLDINGS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for the quarter ending 2019-01-31 was $0.00, a 100.00% decline year-over-year.
- RAFAEL HOLDINGS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for the quarter ending 2018-10-31 was $8.40M.
- RAFAEL HOLDINGS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for the quarter ending 2018-04-30 was $8.40M.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 3 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 6 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 9 month |
|---|---|---|---|
| 2019-04-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-06-05 | $0.00 derived: sum of 2 quarters · filed 2019-06-05 | $8.40M 10-Q · filed 2019-06-05 |
| 2019-01-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-03-12 | $8.40M 10-Q · filed 2019-03-12 | |
| 2018-10-31 | $8.40M 10-Q · filed 2018-12-10 | ||
| 2018-04-30 | $8.40M 10-Q · filed 2018-06-11 | $16.80M derived: sum of 2 quarters · filed 2018-06-11 | |
| 2018-01-31 | $8.40M 10-Q · filed 2018-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |